Gene: TXNDC17
Official Full Name: thioredoxin domain containing 17provided by HGNC
Gene Summary: Enables peroxidase activity and protein-disulfide reductase (NAD(P)H) activity. Involved in tumor necrosis factor-mediated signaling pathway. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KO24616 | TXNDC17 Knockout cell line (HeLa) | Human | TXNDC17 | 1:3~1:6 | Negative | Online Inquiry |
| KO24617 | TXNDC17 Knockout cell line (HCT 116) | Human | TXNDC17 | 1:2~1:4 | Negative | Online Inquiry |
| KO24618 | TXNDC17 Knockout cell line (HEK293) | Human | TXNDC17 | 1:3~1:6 | Negative | Online Inquiry |
| KO24619 | TXNDC17 Knockout cell line (A549) | Human | TXNDC17 | 1:3~1:4 | Negative | Online Inquiry |
TXNDC17 Gene Knockout Cell Lines represent a cutting-edge product designed for researchers focused on the investigation of cellular functions and disease mechanisms associated with the TXNDC17 gene. These cell lines are genetically engineered to have a complete knockout of the TXNDC17 gene, which encodes a thioredoxin domain-containing protein involved in critical cellular processes, including protein folding, redox regulation, and stress response. By disabling this gene, researchers can directly study its role and the biological consequences of its absence, offering insights into cellular pathways perturbed in various diseases.
The key functions of these knockout cell lines hinge on the principle of gene loss-of-function studies, allowing scientists to dissect the biological implications of TXNDC17 deficiency. Researchers can employ these cell lines in a variety of experimental setups, including assays related to oxidative stress, apoptosis, and signaling pathways involved in cellular homeostasis. By examining phenotypic changes and responses to external stimuli, users can gain valuable information regarding the molecular mechanisms underpinning diseases such as cancer, neurodegenerative disorders, and metabolic syndromes.
The scientific importance of TXNDC17 Gene Knockout Cell Lines extends into clinical research, where understanding the function and regulation of this gene may unveil potential biomarkers or therapeutic targets. These cell lines offer a unique opportunity to model diseases in vitro, potentially accelerating the discovery of novel treatment strategies.
What sets our TXNDC17 Gene Knockout Cell Lines apart from conventional cell lines is their reliability and specificity. Our cells are thoroughly validated to ensure that the knockout is complete, with extensive characterization to support reproducibility in research. Additionally, they are compatible with a range of assays and applications, making them an invaluable tool for both basic and translational research.
This product is undeniably valuable for researchers and clinicians focused on pioneering studies that seek to unravel the complexities of cellular behavior in the absence of TXNDC17. By utilizing our cell lines, users will gain enhanced control over their experimental conditions, leading to more robust and meaningful findings.
Our company has a proven track record in the field of genetically engineered cell lines, equipped with the expertise to support researchers from initial design to implementation, ensuring that you receive optimal products tailored to your research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.